This study investigates the involvement of the c-cbl protooncogene in thymocyte apoptosis occuring in vivo after hydrocortisone treatment. In the thymus of untreated mice, a few medullary and cortical thymocytes expressed p120 cbl , mainly in the cytoplasm. In the cortex, their number and distribution resemble that of apoptotic cells evidenced by TUNEL staining. The expression of Cbl is rapidly increased when apoptosis is triggered by hydrocortisone. This Cblspecific immunostaining was detected in the nucleus and is due to a Cbl-related 90 kDa protein (CARP 90). These results show that a c-cbl product could localize in the nucleus and suggest that it could be involved as a regulator of thymic apoptosis.
Introduction
The protooncogene c-cbl has been shown to be ubiquitously expressed through Northern blot analysis of murine tissues with a preferential and spontaneous expression in the thymus and the testis. 1 Two functional transcripts of 3.5 and 10.5 kb have been described, the larger form being predominant in the thymus.
The protein product of c-cbl, p120 cbl or Cbl, has several distinctive domains including a YY-1 transcription factor-like basic region and a potential nuclear localization signal (NLS) in the N-terminal region, a RING finger motif, a large proline and serine/threonine rich domain, a leucine zipper like motif at the C-terminus 2, 3 and a potential phosphotyrosine binding (PTB) domain. 4 Most of these features suggest that c-Cbl could function as a transcription factor. However, different studies have shown that Cbl does not localize in the nucleus, unlike the product of v-cbl which is a fusion of the first 357 amino-acid residues of p120 cbl , retaining the NLS, to the viral gag sequences. 5 Numerous recent studies rather lead to the assumption of a central role for Cbl in signal transduction. Indeed, p120
cbl is rapidly phosphorylated on tyrosine upon activation of cells through a number of receptor tyrosine kinases as well as non-receptor tyrosine kinases. Tyrosine phosphorylation of Cbl was observed after integrin signaling activation in macrophages. 6 Cbl is also phosphorylated in cells transformed by v-Src, v-Abl and Bcr-Abl. 2, 7, 8 Cbl is associated with tyrosine kinases either constitutively (srcfamily kinases) or inducibly (EGFR, PDGFRa, Syk/ZAP-70 family in lymphocytes). It also interacts with a number of signaling molecules such as Crk/CrkL, Vav, PI3K, Grb-2 and 14-3-3 proteins (for review: 4,9,10±15 ). Much of our knowledge about c-cbl is based on studies made on cell lines in vitro, and despite its high specific physiologic expression in the thymus, the role of c-cbl in thymocytes is not well understood yet.
The establishment of the T-cell repertoire in the thymus is achieved following different steps including positive and negative selection (for review: 16 ) During selection, most unresponsive or potentially autoreactive thymocytes are eliminated by apoptosis. 17 Thus, T-cell development requires proliferation, differentiation and apoptosis. In vitro stimulation of human thymocytes with anti-CD3 antibodies plus a comitogenic factor such as IL-1 or PMA downregulated the high level of c-cbl expression observed in the presence of anti-CD3 alone. 18 These results suggest that thymocyte proliferation requires a down-regulation of c-cbl mRNA. They are consistent with the negative regulation which Cbl is believed to exert on diverse tyrosine kinases (Syk/ZAP-70 family, 19 EGF and PDGFa receptors 20 ) . Our data also showed that the c-cbl mRNA level notably and rapidly increased through CD3 stimulation which leads to thymocyte apoptosis. 18 As apoptosis is required for T-cell development, this prompted us to investigate the in vivo expression of Cbl after induction of thymocyte apoptosis by glucocorticoids.
The present paper describes the expression of c-cbl mRNA and the presence as well as the subcellular localization of the protein product(s) in the normal mouse thymus and after apoptosis induction in vivo. Our results confirm the expression of c-cbl transcripts and show their appearance around birth. They demonstrate the cytoplas-mic presence of p120 cbl in thymocytes of untreated mice, mainly in the cortex. During experimentally induced apoptosis, we show a very rapid increase and a nuclear localization of a 90 kDa c-cbl protein product, preceeding the cleavage of the nuclear chromatin, characteristic of apoptosis.
Results c-cbl transcripts are expressed in the neonatal and in the adult thymus
The pattern of expression of the proto-oncogene c-cbl was studied by in situ hybridization using ( 35 S)RNA c-cbl specific 10.7 kb probe.
c-cbl expression was studied in fetal thymuses from embryonic stages E14 to E20 and during the neonatal period. The distribution and density of silver grains indicate that c-cbl starts to be expressed around birth in the cortex ( Figure 1A ) and at the cortico-medullary junction.
In the thymus of young adult C57BL mice ( Figure 1B ), ccbl expression was observed mainly in the cortex: the density of silver grains in the cortical region was higher than that detected in the medulla (not presented on the picture); these grains are uniformly dispersed in these regions. As compared with control sense probe hybridizations ( Figure 1D ), these levels of expression can be considered as significant.
Thus, c-cbl transcripts were not present in the fetal thymus and started to be detected around birth. They persisted mainly in the thymus cortex during adult life.
The p120 cbl protein is expressed in the thymus
To investigate the c-cbl expression at the protein level, immunohistochemistry was performed on thymus sections from untreated 1-month-old adult mice (Figure 2A ), using a rabbit polyclonal antibody directed against the last 15 amino acids at the carboxy terminus of p120 cbl . This experiment revealed that c-cbl product(s) are present mainly in the cytoplasm of isolated lymphoid cells scattered in the cortex, but also in medullary thymocytes and some stromal cells.
Western blots analysis of total thymic extracts, with the same antibody, showed a signal clearly detectable at 120 kDa, confirming that p120
cbl is indeed present in the thymus of untreated adult mice.
The cleavage of nuclear chromatin characteristic of apoptosis is detected in the neonatal and in the adult thymus Experiments described above revealed the presence of c-cbl transcripts and protein products mainly in areas of the thymus where apoptosis is thought to occur. We thus examined a biochemical marker for apoptosis, the cleavage of nuclear chromatin. Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-FITC nick end-labeling (TUNEL) detects DNA strand breaks in cells undergoing apoptosis. Thus, unlike normal cells, nuclei of apoptotic cells incorporate exogenous nucleotides (dUTP-FITC) in the presence of TdT. When amplified with a two step staining procedure, the TUNEL method readily detects apoptotic cells in cryostat sections.
In the adult thymus (Figure 3Aa ), some isolated TUNEL stained cells were mainly found in the cortex; very few positive cells were detected in the medulla. TUNEL positivity in the fetal thymus was quite low or absent starting to be detected by day 2 after birth, mostly in the cortex and at the cortico-medullary junction where their density was higher than in the adult thymus.
Hydrocortisone very rapidly increased c-cbl products (Cbl) expression and induced a nuclear localization of these products before the onset of apoptosis
The scarceness of apoptotic thymocytes observable in a thymus section, probably due to the rapid elimination of dead cells in vivo, makes the correlation between Cbl expression and apoptosis difficult to establish. To bypass this limitation and to check whether Cbl expression was modified when thymocytes undergo apoptosis, we used hydrocortisone for the in vivo induction of massive apoptosis inside the thymus. 21 Hydrocortisone induced a rapid and marked increase in the number of apoptotic cells, mainly in the cortex, but also in the medulla; the apoptotic cells were detected as soon as 2 h after the injection and aggregated in large clusters, mainly in deep cortex and at the cortico-medullary junction (Figure 3Ab ).
Agarose gel electrophoresis of DNA confirmed the occurrence of apoptosis in thymuses of hydrocortisonetreated mice ( Figure 3B ).
Then, we examined the pattern and the time course of Cbl expression in the thymus after apoptosis induction by hydrocortisone injection. We observed a very early increase in the number of cells stained with anti-Cbl antibodies: as soon as 15 min after hydrocortisone treatment ( Figure 2B ), many positive cells which still display a healty morphology were detected. During the earlier part of the time course experiment, as apoptosis was occuring (15 min to 6 ± 8 h after the treatment), the labeling intensity increased, as well as the number of positive cells. In most of these cells, an anti-Cbl immunoreactive product was present in the nucleus, while some cells seemed to express Cbl only in their cytoplasm. No staining was observed when sections were incubated with antibody pre-incubated with the immunogen peptide in an appropriate ratio (P15) ( Figure  2D ). Then, when apoptosis had already occured (16 ± 48 h after the treatment), we observed almost no more Cbl immunostaining ( Figure 2C ).
Nuclear immunoreactivity with anti-Cbl antibodies is due to the presence of a 90 kDa protein
The observations made by light microscopy after immunostaining seem to indicate that Cbl expression is increased and present in the nucleus when thymic apoptosis is triggered. To confirm this nuclear localization, c-cbl products were further analyzed on cytoplasmic and nuclear thymocyte extracts by immunoprecipitations with anti p120 cbl , followed by Western blotting with the same antibody.
In normal thymocytes, two immunoreactive forms were observed: p120 cbl in the cytoplasm ( Figure These results support the specificity of the signals. In this experiment, immunoprecipitations were done on the same amount of protein from cytoplasmic or nuclear extracts.
Another time course experiment showed a drastic appearance of p90 in the cytoplasm as soon as 5 min after hydrocortisone treatment (data not shown), and a progressive increase in the nucleus between 15 and 30 min ( Figure 4B ). These data confirm the nuclear localization as well as the increasing nuclear expression of p90 already 15 min after treatment ( Figure 4A , lane 3), reaching a peak 1 h after treatment ( Figure 4B ). This could be ascribed to a progressive recruitment of cells undergoing such a phenomenon and/or to an accumulation of the nuclear ccbl related product in these cells. We concluded that the nuclear as well as part of the cytoplasmic staining with the anti-Cbl antibody on thymic sections is due to the presence of this Cbl immunoreactive 90 kDa protein. Its weak constitutive presence within the nucleus of normal control thymocytes ( Figure 4A , lane 1) could be due to the physiological and basal apoptosis occurring in the thymus.
An increase of c-cbl mRNA level following hydrocortisone treatment occurs later on after the accumulation of c-cbl protein products
To further investigate how Cbl could be up-regulated by apoptosis inducers, the pattern and time course of c-cbl mRNA expression was analyzed by in situ hybridization on thymus sections after apoptosis induction as described above.
Fifteen and 30 min after apoptosis inducing treatment, the hybridization signal was equivalent to that found in thymuses of untreated mice. High levels of c-cbl transcripts were found only 1 to 2 h thereafter, when many apoptotic cells had already been observed, mainly in cell clusters in the cortex of hydrocortisone-treated mice ( Figure 1C ).
These data suggest that a neosynthesis of the p90 does not account for the very early accumulation of this protein following apoptogenic treatment.
Discussion
The c-cbl product, p120 cbl , contains several features distinctive of transcription factors, particularly a putative nuclear localization signal (NLS), a YY-1 transcription factorlike basic region, a putative leucine zipper and a zinc fingerrelated protein motif. The truncated protein encoded by v-cbl can enter the nucleus and bind to DNA. 22 However, p120 cbl has never been shown to localize in the nucleus but rather seem to be involved in signal transduction within the cytoplasm of various cell lines. The main c-cbl constitutive expression within the thymus and its apparent lack of involvement in cell-cycle processes 18, 23 prompted us to explore Cbl fate through another major event occurring in the thymus, apoptosis.
Potent apoptosis inducer such as hydrocortisone led to a rapid increase of Cbl expression, markedly in the nucleus, as shown by immunohistochemistry experiments, both in the cortex and the medulla. This increase preceded the DNA fragmentation characteristic of apoptosis. These data led us to the assumption that c-cbl could play a role in thymic apoptosis regulation, but also suggested that this function could depend on the cell type, the developmental stage and the microenvironment influence, as it is the case for c-rel. 24 Immunoprecipitation followed by immunoblotting with anti-Cbl antibody (C-15) showed that a c-Cbl immunoreactive protein of 90 kDa is mainly involved in the nuclear immunostaining whereas p120 cbl stays in the cytoplasm.
Similar in situ immunostaining was observed after treatment with other potent thymocyte apoptosis inducers such as 4 Gy irradiation or anti-CD3 monoclonal antibody. A p90 nuclear Cbl-immunoreactive form was also detected after the same treatments (data not shown). These results indicate that c-cbl may have a nuclear p90 form tightly associated to the occurence of thymic apoptosis and suggest a critical role for p90 in apoptosis regulation. We named this protein CARP 90 for Cbl and Apoptosis Related Protein 90 kDa.
The rapid appearance of this p90 in the cytoplasm before it could be detected at a high level in the nucleus strikingly suggests a nuclear transport event, even if a nuclear accessibility to anti-Cbl antibody upon apoptosis inducer treatments cannot be ruled out.
This p90 is likely related to the c-cbl proto-oncogene according to the following observations: (a) there is no protein known in the data bank which shares significative homologous sequence within the peptide sequence recognized by the anti-Cbl antibody used in these experiments (C-15); (b) the cbl immunoreactive signal at 90 kDa following thymic Cbl immunoprecipitation after apoptosis induction is reproducibly higher than the p120 cbl signal ( Figure 4A, lane 5) . This c-Cbl immunoreactive p90 could be a product of a closely related gene. In this respect, the proto-oncogene cbl-b, which shares a high homology with c-cbl 25 is not a good candidate, since the polyclonal antibody used in these experiments (C-15) is described as not cross-reacting with cbl-b products. The Cbl related p90 was also precipitated and reactive in immunoblotting with a polyclonal anti-Cbl-b antibody crossreacting with large parts of p120 cbl (29 ± 483 amino acids region). Conversely, two other anti-Cbl-b antibodies, which do not cross-react with p120 cbl , were unable to precipitate nor detect p90 (data not shown). However, as these two antibodies are directed against the 19 first amino acids at the N-terminus and against the last 20 amino acids at the C-terminus of Cbl-b, it is thus possible to hypothesize that these sequences have been lost, resulting in a truncated form. At last, a monoclonal antibody (Transgene Labora- There is no immunoprecipitation when anti-Cbl antibody was blocked with the P15 blocking immunogen peptide in a sufficient ratio (lanes 2, 6 and 8). Incubation of the antibody with diluted P15 led to a decrease in the p90 signal in the nucleus (lane 4 compared to lane 3) confirming the Cbl specificity of the antibody recognition. Tracks were equimolarly loaded. (B) Immunoprecipitation and immunoblotting with the same anti-Cbl antibody on thymic nuclear extracts from untreated (lane 1) or treated animals. As compared to the previous experiment, immunoprecipitation was done on a five to ten lesser amount of nuclear proteins and nevertheless led to a very high p90 signal 30 min and more after hydrocortisone treatment (lanes 4 and 5) tories, clone 17), directed against a p120 cbl region comprised between amino acids 595 and 810, could detect p90 (and p120) (data not shown). So, p120 cbl , having been suspected for a long time to be a transcription factor according to its sequence, could reasonably be linked to this strongly c-Cbl immunoreactive nuclear protein of 90 kDa (CARP 90) shown for the first time in the thymus. The originality of our work lies in that we have investigated the Cbl expression in an apoptosis model by immunohistochemistry and immunoprecipitations on fractionated extracts, as nobody had done yet. That could partially but reasonably explain why almost nobody had ever been able to observe nuclear products of c-cbl, before our own data.
In order to correlate p90 with c-cbl mRNA, the pattern and time course of c-cbl mRNA expression were investigated by in situ hybridization on thymus sections after in vivo apoptosis induction by hydrocortisone injection. The hybridization signal was not significantly different within 30 min following the treatment as compared to untreated animals (data not shown). After 1 ± 2 h, when a high number of apoptotic cells was already being observed, we noticed a striking change with many c-cbl transcripts mainly found in numerous large clusters of cortical cells ( Figure 1C ). The strongest modifications were observed 2 h after treatment while Cbl immunoreactive protein(s) were detected very early (15 ± 30 min) after the same treatment, by immunohistochemistry on thymic sections ( Figure 2B ) or by immunoprecipitation ( Figure 4A ) with anti-Cbl antibody. These data suggest that a neosynthesis of CARP 90 does not account at least for the very rapid increase of the protein levels following apoptogenic treatment.
As evoked above, the rapid appearance of a Cbl immunoreactive protein of 90 kDa in the cytoplasmic extract after treatment ( Figure 4A ) could be due to the unmasking of epitopes recognized by the anti-Cbl antibody following the treatment. The nuclear presence of p90 could be associated with an unmasking of the putative NLS through either an intra-molecular event (as it is the case for NF-AT4 26 ), a proteolytic maturation cleavage of p120 cbl or the release of one or more potential binding proteins. Closely related to this situation is the rapid degradation of IkBa when cells are exposed to NF-kB inducers, allowing the transcriptional complex to translocate into the nucleus. 27 Apoptosis inducers could have the same effect on a complex containing p90. Moreover, these results are reminiscent of the transcription factor c-rel, which has been shown to translocate into the nucleus of avian thymocytes during the time course of apoptosis through a posttranscriptional induction. 28 As for the hypothesis that the Cbl immunoreactive p90 could result from a proteolytic post-translational event, we could refer to Widmann et al. 29 who have shown that Cbl was cleaved in Jurkat and U937 cells undergoing apoptosis induced by different stimuli. This cleavage occured rather late in the apoptotic process and thus seemed to be a consequence rather than an initiating event of apoptosis in their system, contrasting with the early appearance of CARP 90 after apoptosis induction in our experiments. In their study, it appeared that Cbl cleavage was caspaseactivation dependent, but DEVD-directed caspases, e.g. caspase-3 family, were not involved. Furthermore, Miyashita et al. 30 showed that the glucocorticoid-induced apoptotic pathway would involve the processing of caspase-6 rather than caspase-3 activation. Furthermore, CPP32 (caspase-3) would not play any key role in T cell selection. 31 On the other hand, caspases are not the only proteases involved in apoptosis. In this respect, it is noteworthy that Widmann et al. 29 still detected a Cblrelated product after Fas ligation and caspases inhibition in Jurkat cells. The pattern of p120 cbl cDNA in vitro transcribed and translated proteins in our own system was similar to that obtained by Widmann et al. 29 (data not shown), i.e. a 85 kDa Cbl-related product was detected by the C-15 anti-Cbl antibody. This 85 kDa product could result from an internal initiation of translation or from a proteolytic event due to proteases inside the reticulocyte lysate system. Thus, it is possible that the Cbl-related product at 85 kDa obtained in vitro corresponds to the p90 found in vivo.
Experiments are currently performed to analyze the pattern when in vitro products are incubated with apoptosis-induced thymocytes.
As the sequence recognized by the polyclonal antibody used in our experiments is located at the C-terminus part of p120 cbl , we could imagine p90 as a proteolytically processed form of c-Cbl lacking some N-terminal sequence. However, even if the existence of a cryptic NLS cannot be ruled out, the transcription factor-like basic region and the putative NLS are located in the aminoterminal part of c-Cbl. Alternatively, p90 could be the product of an alternative spliced c-cbl mRNA. This hypothesis is currently being examined by RT ± PCR approach.
If p90 is related to c-cbl, it will be of great interest to investigate and compare its function(s) with those of p120 cbl . The large diversity of protein family members with different functions is well documented. For example, each STAT family member contributes to specific biological activities but all are transcription factors. 32 A precedent for c-cbl could be the Ikaros isoforms with distinct subcellular compartmentalization suggesting their participation in distinct regulatory pathways either in the cytoplasm or in the nucleus. 33 It is noteworthy that p120 cbl can bind with diverse proteins involved in apoptosis under certain circumstances, e.g. with p85 PI3K 34,35, p59 fyn 36 , c-Abl 37 or 14-3-3 proteins. 38 Thus, it would be interesting to investigate potential associations of p90 with other proteins, including p120 cbl . Furthermore, p120 cbl has been involved in inhibitory and/ or proteolytic regulation related processes.
19,39 ± 41 Indeed, recent biochemical studies in mammalian cells, C. elegans and Drosophila have identified the proto-oncogene product Cbl as a possible negative regulator of tyrosine kinases (for review: 4;42,43 ). Particularly, Crk proteins could link Cbl to a small G-protein signaling pathway that may antagonize Ras signaling. It has also been claimed that Cbl enhances the ubiquitination and degradation of the PDGFRa 44 and the EGFR. 45 Interestingly, c-cbl is localized within the same gene cluster as the gene coding for the transcription factor Ets-1 46 which would delay thymic apoptosis. 47 Cbl knock-out mice have recently been generated independently by two groups. According to Murphy et al.
19 cbl 7/7 mice display hyperplastic histological changes and enhanced T-cell signaling via ZAP-70, but correct ratio between thymic CD4/CD8 subpopulations and a thymic cellularity that is only transiently increased. Naramura et al. 48 obtained similar results and showed an enhanced thymic positive selection in Cbl-deficient mice. Although the role of Cbl in controlling cellular proliferation as a negative regulator of tyrosine kinases is becoming more and more evident, a potential role of Cbl in apoptosis regulation would be worthy of investigation in these Cbl-deficient mice.
Our data as well as the c-cbl ORF sequence analysis 2, 3 suggest that the c-cbl product(s) and particularly CARP 90 could exert a regulation, either positively or negatively, on apoptosis as transcription factor(s) at least in immature T cells.
Material and Methods

In situ hybridizations
In situ hybridizations were done as described 49 with 35 S-labeled RNA probes prepared from a 500 bp PstI-EcoRI of a 5' v-cbl/c-cbl identity region. 23 Fifty microliters of probe mixture of 50% formamide containing NaCl (0.6 M), Tris-HCl (10 mM), EDTA (1 mM), 1% SDS, DTT (10 mM), yeast t-RNA (0.25 mg/ml; Boehringer Mannheim), 16Denhardt's (506Denhardt's=1% Ficoll, 1% polyvinylpyrrolidine, 1% BSA), 10% PEG-6000 (polyethylene glycol-6000) and 1 ml of labeled RNA (150,000 c.p.m./ml) were loaded on each slide and hybridization was performed at 508C overnight in a humid chamber. As negative controls, some slides were pretreated for 2 h at 378C in a solution containing 20 mg/ml of RNAse to destroy the mRNA or, in some cases, the antisense probe was replaced by the sense probe. Slides were then washed twice for 5 min with PBSM (phosphate buffer saline containing 5 mM MgCl 2 ), rinsed 30 min in a solution containing 20 mg/ml of RNAse (Boehringer Mannheim) in 0.5 M NaCl and 10 mM Tris-HCl (pH 8) at 378C, 30 min in the same solution except RNAse at 378C, 30 min with 50% formamide/26SSC (26SSC=0.3 M NaCl, 0.03 M sodium citrate) at 508C, 30 min with 50% formamide/16SSC, and 30 min in 50% formamide/16SSC containing 0.05% of Triton X-100 at 378C. The slides were then dehydrated successively in 30, 50 and 70% ethanol in 300 mM ammonium acetate (pH 7), air dried, and finally autoradiographed. Ilford K2 emulsion was diluted with an equal volume of 300 mM ammonium acetate. The slides were dipped into the emulsion and allowed to solidify horizontally at room temperature for 4 h. The emulsion-coated slides were kept at 48C for 8 ± 10 days for exposure. They were developed in Kodak D-19 developer (Eastman Kodak, Rochester, NY, USA) for 3 min. After a rinse in a 1% acetic acid solution, the fixation was carried out in an Ilford rapid fixer for 6 min and the slides were washed twice with water for 30 min. They were stained with hematoxylin-eosin for 2 min, washed twice with water, and air dried. We considered as positive cells (cells expressing mRNAs) those cells that had more than eight grains per cell. Dark-field photomicrographs were obtained with a Leitz Laborlux.
Apoptosis detection
TUNEL assays were performed on frozen sections according to procedures previously described (In situ cell death detection kit, AP, Boehringer Mannheim). Sections were fixed 20 min in paraformaldehyde 4% at room temperature and possibly dehydrated 2 min in pure alcohol for conservation at 7208C before further processing. Sections were permeabilized (Triton X-100 0.1% in sodium citrate 0.1%) 10 min at 378C, and then incubated 1 h at 378C with 50 ml of a mixture containing TdT enzyme and FITC-labeled nucleotides. Converter AP was then applied for 30 min at 378C. Alkaline phosphatase was finally revealed with New Fushine (DAKO) and sections were counterstained.
Internucleosomal DNA fragmentation was assessed by DNA electrophoresis. 50 Briefly, cells were washed twice with PBS and spun at 2006g for 5 min at room temperature. Cell pellets were resuspended at 10 7 cells/ml in cell lysis bufer (10 mM EDTA, 50 mM Tris, 0.5% SDS) and incubated for 1 h at room temperature. Proteinase K 10 mg/ml (Boehringer Mannheim) was then added and incubation was continued for 3 h at 378C. The crude DNA preparations were then extracted with phenol/chloroform. The aqueous phase was made 100 mM NaCl and precipitated overnight with 2 volumes of ethanol at 7208C. After centrifugation at 13 0006g for 10 min, pellets were air-dried, resuspended in 80 ml of TE (10 mM Tris, 1 mM EDTA) containing RNAse (100 mg/ml; Sigma) and incubated for 4 h at 378C. The crude DNA preparation was extracted as described before. Electrophoresis of DNA was carried out in 1.8% agarose gel. Prior to electrophoresis, 40 ml of TE and 4 ml of bromophenol blue were added to each sample. The samples were then treated to 658C for 5 min in a water bath. The electrophoresis was carried out at 40 V in a TAE buffer (0.04 M Tris-Acetate, 0.001 M EDTA, pH 9) during 4 h. An HaeIII digest of f174 RF DNA was applied to provide size markers. DNA was visualized by bromide staining and UV transillumination.
Immunohistochemistry
Immunochemistry was performed on 2 mm thin histological sections done in 4% paraformaldehyde fixed and JB4 (Polysciences) embedded tissues. Sections were permeabilized with trypsine 0.25% for 10 min at 378C, and then with Tween 20 2% for 30 min at 378C. Endogenous peroxidases were quenched by incubation with H2O2 1% for 30 min at room temperature. Aspecific sites were saturated with normal goat serum 1.5% during 1 h at 378C. Sections were then incubated overnight at 48C with primary polyclonal rabbit anti-cbl antibody at the concentration of 0,4 mg/ml (C-15, Santa Cruz Biotechnology) and then for 2.5 h with biotinylated goat anti-rabbit antibody. This latter was detected by ABComplex (Novostain Super ABC Kit, Novocastra). Peroxidase was revealed using diaminobenzidine (DAB) (Dako) which gives a brown precipitate in the presence of H 2 O 2 . Sections were counterstained with methyl green 0.1% (Sigma). The specificity was successfully tested by incubating sections with normal rabbit serum instead of primary antibody, or with antibody preincubated with control peptide (SantaCruz Biotechnology).
Subcellular fractionation, immunoprecipitation and Western blottings
All manipulations were done at 48C. Subcellular fractionation was carried out as described. 20 Thymi from treated or untreated 4 weeksold animals were disrupted with a Dounce homogenizer (pestle A) for 5 min in lysis buffer A (300 mM Saccharose, 15 mM NaCl, 60 mM KCl, 2 mM EDTA, 15 mM HEPES, 1 mM DTT, 1 mM PMSF, 4 mM NaVO3, 100 mM NaF, 30 mM NaP2O7, 0.5% aprotinine). After a 10 0006g centrifugation for 2 min, supernatants were collected as cytoplasmic extracts. Pellets were washed (NP40 0.3% in lysis buffer A) and then disrupted into the Dounce homogenizer (pestle B) for 12 min in lysis buffer B (1.1 M urea, 330 mM NaCl, 0.01% NP40, 27.5 mM HEPES, 1 mM DTT, 1 mM PMSF, 4 mM NaVO3, 100 mM NaF, 30 mM NaP2O7, 0.5% aprotinine) and the lysates were centrifuged for 15 min at 100006g. Supernatants contained nuclear proteins. Protein concentrations were determined using the Bio-Rad protein assay according to Bradford method (595 nm). Extracts were immunoprecipitated for 2 h with anti-Cbl antibody in excess and then 5 mg of Staphylococcus aureus Protein A Sepharose beads (CL-4B, Pharmacia Biotech Inc.) in 50 ml of lysis buffer A were added and incubation was carried out for 45 min. Specificity was tested by preincubating the antibody with blocking peptide P15 in excess (1 mg/ml) for 3 h at 48C. After a 25006g centrifugation for 2 min, pellets were washed three times (PBS-Triton 0.1%; PBS-NaCl 0.5 M, PBS only). Immunoprecipitates were boiled with 25 ml of sample buffer (Tris-Hcl 50 mM pH 6.5, bromophenol blue 0.05%, b mercaptoethanol 5%, glycerol 10% and SDS 2%) for 2 min, immediately refreshed on ice and centrifuged. 20 ml supernatant were loaded on 10% SDS ± PAGE.
Proteins were transferred to PVDF membranes (TransBlot BioRad) and Western blot analysis was then performed with the C-15 anti-Cbl rabbit polyclonal antibody as primary antibody and Aurora Westernblotting detection reagent according to the instructions provided by the supplier (ICN Biomedicals).
